USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2013 | -251.11 USD | 99.74% |
2012 | -155.96 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2014 Q3 | -101.47 Thousand USD | -37.42% |
2014 Q1 | -19.67 Thousand USD | 99.12% |
2014 Q2 | -73.83 Thousand USD | -275.38% |
2013 Q4 | -2.24 Million USD | -3935.45% |
2013 Q3 | -55.58 Thousand USD | 10.4% |
2013 FY | - USD | 99.74% |
2013 Q1 | -2049.00 USD | 96.56% |
2013 Q2 | -62.03 Thousand USD | -2927.57% |
2012 FY | - USD | 0.0% |
2012 Q4 | -59.62 Thousand USD | -142.04% |
2012 Q3 | -24.63 Thousand USD | -168.17% |
2012 Q2 | 36.13 Thousand USD | 210.14% |
2012 Q1 | -32.8 Thousand USD | 98.99% |
2011 Q2 | -1.01 Million USD | 37.05% |
2011 Q3 | -52.19 Thousand USD | 94.84% |
2011 Q4 | -3.25 Million USD | -6131.56% |
2011 Q1 | -1.6 Million USD | -4708.51% |
2010 Q1 | -64.18 Thousand USD | -56.55% |
2010 Q4 | -33.42 Thousand USD | -439.27% |
2010 Q3 | -6198.00 USD | 15.1% |
2010 Q2 | -7300.00 USD | 88.63% |
2009 Q2 | -4004.00 USD | -18.01% |
2009 Q1 | -3393.00 USD | 0.0% |
2009 Q3 | -4417.00 USD | -10.31% |
2009 Q4 | -41 Thousand USD | -828.23% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Allstar Health Brands, Inc. | -241.78 Thousand USD | 99.896% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 100.0% |
Café Serendipity Holdings, Inc. | -1.41 Million USD | 99.982% |
Decision Diagnostics Corp. | - USD | Infinity% |
Health Advance Inc. | -47.95 Thousand USD | 99.476% |
HealthWarehouse.com, Inc. | -1.27 Million USD | 99.98% |
LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 100.001% |
MedGen, Inc. | -15.37 USD | -1533.767% |
Omni Health, Inc. | 1.28 Million USD | 100.02% |
Oxford Investments Holdings Inc. | -343.96 Thousand USD | 99.927% |
Pineapple, Inc. | -1.47 Million USD | 99.983% |
ScripsAmerica, Inc. | -3.95 Million USD | 99.994% |